Presence of Ascites at Presentation is Associated With Absence of Long-Term Response Amongst Patients With Budd-Chiari Syndrome When Treated With Medical Therapy Alone: A Single Centre Real-Life Experience

Journal of Clinical and Experimental Hepatology - Tập 12 - Trang 861-870 - 2022
Dhiraj Agrawal1, Deepak Gupta1, Rohit Nathani1, Prashant Dhore1, Megha Meshram1, Shobna J. Bhatia1, Akash Shukla1
1Department of Gastroenterology, Seth GSMC and KEM Hospital, Mumbai 400 012, India

Tài liệu tham khảo

Plessier, 2006, Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome, Hepatology, 44, 1308, 10.1002/hep.21354

Seijo, 2013, European Network for Vascular Disorders of the Liver. Good longterm outcome of Budd-Chiari syndrome with a step-wise management, Hepatology, 57, 1962, 10.1002/hep.26306

DeLeve, 2009, Vascular disorders of the liver, Hepatology, 49, 1729, 10.1002/hep.22772

Zeitoun, 1999, Outcome of Budd–Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting, Hepatology, 30, 84, 10.1002/hep.510300125

Linkins, 2003, Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a metaanalysis, Ann Intern Med, 139, 893, 10.7326/0003-4819-139-11-200312020-00007

Malinchoc, 2000, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts, Hepatology, 31, 864, 10.1053/he.2000.5852

Darwish Murad, 2004, Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome, Hepatology, 39, 500, 10.1002/hep.20064

Rathod, 2017, Endovascular treatment of budd chiari syndrome: single centre experience, J Gastroenterol Hepatol, 32, 237, 10.1111/jgh.13456

Min, 1997, Reassessing the role of medical therapy in the management of hepatic vein thrombosis, Liver Transplant Surg, 3, 423, 10.1002/lt.500030410

Sakr, 2017, Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: a single-center study, World J Gastroenterol, 23, 629, 10.3748/wjg.v23.i4.629

Qi, 2015, Survival and prognostic indicators of Budd–Chiari syndrome: a systematic review of 79 studies, Expet Rev Gastroenterol Hepatol, 9, 865, 10.1586/17474124.2015.1024224

Rautou, 2009, Prognostic indices for budd – chiari syndrome: valid for clinical studies but insufficient for individual management, Am J Gastroenterol, 104, 1140, 10.1038/ajg.2009.63